ME00578A - Use of gastrointestinal lipase inhibitors - Google Patents

Use of gastrointestinal lipase inhibitors

Info

Publication number
ME00578A
ME00578A MEP-903/08A MEP90308A ME00578A ME 00578 A ME00578 A ME 00578A ME P90308 A MEP90308 A ME P90308A ME 00578 A ME00578 A ME 00578A
Authority
ME
Montenegro
Prior art keywords
lipase inhibitors
gastrointestinal lipase
gastrointestinal
inhibitors
medicaments
Prior art date
Application number
MEP-903/08A
Other languages
English (en)
Croatian (hr)
Inventor
Jonathan Brian Hauptman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21894047&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ME00578(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ME00578A publication Critical patent/ME00578A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MEP-903/08A 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors ME00578A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3738397P 1997-02-05 1997-02-05
PCT/EP1998/000468 WO1998034630A1 (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Publications (1)

Publication Number Publication Date
ME00578A true ME00578A (en) 2011-12-20

Family

ID=21894047

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-903/08A ME00578A (en) 1997-02-05 1998-01-29 Use of gastrointestinal lipase inhibitors

Country Status (28)

Country Link
US (1) US6147108A (no)
EP (1) EP1017408B1 (no)
JP (1) JP2001509173A (no)
KR (1) KR100479968B1 (no)
CN (1) CN1154505C (no)
AR (1) AR011106A1 (no)
AT (1) ATE292975T1 (no)
AU (1) AU740375B2 (no)
BR (1) BR9807655A (no)
CA (1) CA2278854C (no)
CZ (1) CZ295567B6 (no)
DE (1) DE69829763T2 (no)
DK (1) DK1017408T3 (no)
ES (1) ES2239799T3 (no)
HK (1) HK1025251A1 (no)
HU (1) HU230834B1 (no)
ID (1) ID22650A (no)
IL (1) IL131007A0 (no)
ME (1) ME00578A (no)
NO (1) NO324452B1 (no)
NZ (1) NZ336755A (no)
PL (1) PL191222B1 (no)
PT (1) PT1017408E (no)
RU (1) RU2201272C2 (no)
TR (1) TR199901853T2 (no)
WO (1) WO1998034630A1 (no)
YU (1) YU34199A (no)
ZA (1) ZA98753B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001509173A (ja) * 1997-02-05 2001-07-10 エフ・ホフマン−ラ ロシュ アーゲー 胃腸リパーゼ阻害剤の使用
AR025609A1 (es) 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones lipidas solidas
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
DE60138333D1 (de) 2000-03-14 2009-05-28 Unilever Nv Variabele Domänen der schweren Kette eines Antikörpers gegen menschliche Ernährungslipasen und deren Verwendungen
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
US7510849B2 (en) * 2004-01-29 2009-03-31 Glucolight Corporation OCT based method for diagnosis and therapy
UA103758C2 (ru) 2004-07-19 2013-11-25 Биокон Лимитед Конъюгаты олигомеров инсулина, их композиции и применение
US7254429B2 (en) 2004-08-11 2007-08-07 Glucolight Corporation Method and apparatus for monitoring glucose levels in a biological tissue
US8036727B2 (en) 2004-08-11 2011-10-11 Glt Acquisition Corp. Methods for noninvasively measuring analyte levels in a subject
AU2006235535A1 (en) 2005-04-13 2006-10-19 Glt Acquisition Corp. Method for data reduction and calibration of an OCT-based blood glucose monitor
US8217025B2 (en) * 2006-11-17 2012-07-10 Harbor Therapeutics, Inc. Drug screening and treatment methods
ATE477820T1 (de) * 2007-09-12 2010-09-15 Mader S R L Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
EP2219614A1 (en) * 2007-10-15 2010-08-25 Inventis DDS Pvt Limited Pharmaceutical composition of orlistat
BRPI0818004B8 (pt) 2007-10-16 2021-05-25 Biocon Ltd composição farmacêutica sólida administrável por via oral e o processo da mesma.
WO2009111542A2 (en) 2008-03-04 2009-09-11 Glucolight Corporation Methods and systems for analyte level estimation in optical coherence tomography
US8309107B2 (en) * 2008-10-06 2012-11-13 Banner Pharmacaps, Inc. Stable solutions of orlistat for pharmaceutical dosage forms
FR3017536B1 (fr) * 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
JP2019515654A (ja) * 2016-03-16 2019-06-13 ザ ジェイ． デヴィッド グラッドストーン インスティテューツ 肥満及び／又は糖尿病を処置するための方法及び組成物、並びに候補処置薬剤を識別するための方法及び組成物
WO2019018849A1 (en) * 2017-07-21 2019-01-24 Kieu Hoang STATINES (ATORVASTATIN) THAT CAN REDUCE GLYCEMIA LEVEL IN DIABETICS

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5190970A (en) * 1990-10-19 1993-03-02 E. R. Squibb & Sons, Inc. Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
US5345056A (en) * 1991-12-12 1994-09-06 Motorola, Inc. Plasma based soldering by indirect heating
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
TW381025B (en) * 1993-08-05 2000-02-01 Hoffmann La Roche Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor
JP3532999B2 (ja) * 1995-03-24 2004-05-31 株式会社ロッテ 新規なタンニン類およびこれを有効成分とするリパーゼ阻害剤
JPH09227398A (ja) * 1996-02-20 1997-09-02 Zeria Pharmaceut Co Ltd 抗肥満剤
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
JP2001509173A (ja) * 1997-02-05 2001-07-10 エフ・ホフマン−ラ ロシュ アーゲー 胃腸リパーゼ阻害剤の使用

Also Published As

Publication number Publication date
TR199901853T2 (xx) 1999-12-21
CN1246798A (zh) 2000-03-08
DK1017408T3 (da) 2005-08-01
KR20000070733A (ko) 2000-11-25
IL131007A0 (en) 2001-01-28
DE69829763D1 (de) 2005-05-19
NO993717D0 (no) 1999-07-30
NO324452B1 (no) 2007-10-22
NO993717L (no) 1999-10-04
ZA98753B (en) 1998-08-05
CA2278854C (en) 2014-03-04
EP1017408A1 (en) 2000-07-12
CA2278854A1 (en) 1998-08-13
RU2201272C2 (ru) 2003-03-27
HUP0001014A3 (en) 2000-12-28
KR100479968B1 (ko) 2005-03-30
US6147108A (en) 2000-11-14
HUP0001014A2 (hu) 2000-08-28
AU6616998A (en) 1998-08-26
CZ295567B6 (cs) 2005-08-17
JP2001509173A (ja) 2001-07-10
HU230834B1 (hu) 2018-07-30
CN1154505C (zh) 2004-06-23
BR9807655A (pt) 2000-02-15
ID22650A (id) 1999-12-02
CZ265199A3 (cs) 2000-02-16
ATE292975T1 (de) 2005-04-15
NZ336755A (en) 2001-06-29
YU34199A (sh) 2002-08-12
HK1025251A1 (en) 2000-11-10
EP1017408B1 (en) 2005-04-13
WO1998034630A1 (en) 1998-08-13
AR011106A1 (es) 2000-08-02
PT1017408E (pt) 2005-07-29
PL191222B1 (pl) 2006-03-31
ES2239799T3 (es) 2005-10-01
AU740375B2 (en) 2001-11-01
PL334975A1 (en) 2000-03-27
DE69829763T2 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
ME00578A (en) Use of gastrointestinal lipase inhibitors
NO992907L (no) Flat legemiddeltilberedning for applikasjon og frigiving av buprenorfin eller et annet farmakologisk sammenlignbart stoff i munnhulen og fremgangsmÕte for dens fremstilling
DE60121988D1 (de) Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
HUP0301281A2 (hu) Új gyógyászati készítmény
NO20063000L (no) Kombinasjon og farmasøytisk blanding for behandling av diabetes samt anvendelse derav.
NO20020770D0 (no) Anvendelse av monoaminoksidaseinhibitorer for fremstilling av legemidler egnet for behandling av fedme
FI964332A (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
ATE400577T1 (de) Anellierte dihydropyrane
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
ATE243196T1 (de) Piperidine und pyrrolidine
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
NO20014081L (no) Anvendelse av tianeptin i produksjonen av medikamenter til behandling av nevrodegenerative patologier
AP2001002369A0 (en) Pharmaceutical complex.
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
EP0756870A3 (en) Pharmaceutical compositions for topic use on the basis of ketoprofen
WO2002053171A3 (de) Verwendung von 'intermediate-conductance kaliumkanälen und modulatoren zur diagnose und behandlung von krankheiten mit gestörter keratinozytenaktivität
AU2003255429A1 (en) Use of treosulfan and derivatives thereof for treating multiple sclerosis
HRP20040165B1 (en) Citalopram for the treatment of elevated blood pressure
AU2002225097A1 (en) Novel therapeutic use of a thienylcyclohexylamine derivative